Autres langues Pharmagreen Biotech Inc. OTC Markets

Actions

PHBI

US00922N1046

Temps Différé OTC Markets Autres places de cotation 17:11:07 05/10/2021			Varia. 5j.	Varia. 1 janv.
0,0289 ^USD	-.--%		-4,87%	+172,64%

21/02	Pharmagreen Biotech Inc. annonce ses résultats pour le premier trimestre clos le 31 décembre 2023	CI
09/01	Pharmagreen Biotech Inc. annonce ses résultats pour l'exercice clos le 30 septembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Pharmagreen Biotech Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	21/02
Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	09/01
Sub-Penny Momentum Watchlist (TMGI, BEGI, PHBI, ABQQ)	07/11
Pharmagreen Biotech Inc. cancelled the transaction announced on November 2, 2022	02/11
PHBI – Pharmagreen Starts Sales of MaxGenomicTM Supplement on Amazon.com and Develops Its Next Pre-Workout Formulation	05/09/23
Pharmagreen Starts Sales of MaxGenomicTM Supplement on Amazon.Com and Develops Its Next Pre-Workout Formulation	05/09/23
Pharmagreen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	14/08/23
Pharmagreen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	19/05/23
PHARMAGREEN BIOTECH INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	18/05/23
Pharmagreen Biotech Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	14/02/23
PHARMAGREEN BIOTECH INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	14/02/23
Pharmagreen Biotech, Inc. Launches Online Sales for Its MaxGenomic(TM) Supplement Product	08/02/23
PHBI Pharmgreen Launches Online Sales for Its MaxGenomic™ Supplement Product	08/02/23
PHARMAGREEN BIOTECH INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	17/01/23
Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	17/01/23
Pharmagreen Biotech Inc. Auditor Raises 'Going Concern' Doubt	17/01/23
PHARMAGREEN BIOTECH INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	02/12/22
Pharmagreen Appoints Tyrell Crosby, a Professional Athlete, as Its Honorary Sports Ambassador	29/11/22
Pharmagreen Biotech Inc. announced that it expects to receive $0.05 million in funding from JanBella Group, LLC	02/11/22
PHBI Pharmagreen Biotech Appoints Ethan Styles as Vice President of Product Research and Development	22/09/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Pharmagreen Biotech Inc. OTC Markets

Actions

PHBI

US00922N1046

Autres langues

Filtres